<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2026.1763345</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glomerular cell atlas of multi-disease model revealed the characteristic changes of glomerular cell subtypes in diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Huang</surname><given-names>Yan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Shuo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Shuying</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Duan</surname><given-names>Shuzhong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname><given-names>Lan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Jing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Ma</surname><given-names>Liangyan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Ce</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chen</surname><given-names>Qilin</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1868639/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Nephrology Department, The Affiliated Hospital of Chengde Medical University</institution>, <city>Chengde</city>,&#xa0;<country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Metabolic Vascular Disease Group, Hebei Key Laboratory of Panvascular Diseases</institution>, <city>Chengde</city>,&#xa0;<country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Nephrology Children&#x2019;s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents&#x2019; Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Disease</institution>, <city>Chongqing</city>,&#xa0;<country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Qilin Chen, <email xlink:href="mailto:chcmuc70@cqmu.edu.cn">chcmuc70@cqmu.edu.cn</email></corresp>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors have contributed e to this work and share first authorship</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-24">
<day>24</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1763345</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>02</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Huang, Li, Li, Duan, Huang, Wang, Ma, Liu and Chen.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Huang, Li, Li, Duan, Huang, Wang, Ma, Liu and Chen</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-24">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Although a range of glomerular diseases profoundly affect glomerulus-associated cells, a comprehensive understanding of their molecular alterations is still lacking. Here, we performed in-depth analysis of glomerular data from mouse models of primary and secondary glomerulopathies and constructed a multi-disease cellular landscape of glomerular cells. We identified a putative subset of proliferative glomerular endothelial cells(gECs) that highly expresses genetic susceptibility genes associated with multiple glomerular diseases. Podocytes exhibited shared injury-associated cell types across different disease models. A podocyte subset highly expressing <italic>Endou</italic>, <italic>Cd200</italic>, <italic>Lgmn</italic>, <italic>Il18</italic>, <italic>Dmpk</italic>, and <italic>Spon2</italic> was predominantly derived from ob/ob mice, whereas another podocyte subset with high expression of <italic>Selenbp1</italic>, <italic>Lpar1</italic>, <italic>S100a8</italic>, <italic>S100a9</italic>, and <italic>Sult1a1</italic> was mainly observed in adriamycin-induced mice. Mesangial cells shared common injury-related alterations across diseases (high expression of <italic>Cxcl1</italic>, <italic>egr1</italic>, <italic>hspa1b</italic>, <italic>socs3</italic> and <italic>dnajb1</italic>), while ob/ob mice exhibited a distinct mesangial cell subset (high expression of <italic>aldh1a2, thbs1</italic> and <italic>fbln5</italic>). In contrast, the gECs displayed similar molecular changes across different diseases without giving rise to disease-specific subtypes. Intercellular ligand-receptor analysis underpins the recruitment of immune cells by injured mesangial cells and podocytes via specific engagement of pairs such as CXCL and MIF, respectively. Our study systematically elucidates the molecular alterations of glomerulus-associated cells across various diseases, providing a foundation and strategic insights for future targeted therapies tailored to specific glomerular disease contexts.</p>
</abstract>
<kwd-group>
<kwd>cross-disease atlas</kwd>
<kwd>glomerular disease</kwd>
<kwd>mesangial cell</kwd>
<kwd>podocyte</kwd>
<kwd>single-cell RNA sequencing</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was supported by Young Scientists Fund of the National Natural Science Foundation (no. 82300798) and Medical Science Research Project of Hebei (No. 20220409).</funding-statement>
</funding-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="55"/>
<page-count count="15"/>
<word-count count="6655"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The kidney is an extremely important organ in the human body, playing a crucial role in maintaining the stability of the internal environment and normal metabolic processes. The glomerulus is a highly specialized filtration unit composed of capillary tufts, the Bowman capsule, and three layers of filtration membranes. This intricate structure enables the efficient separation of plasma water and small solutes from the blood, thereby forming the primitive urine. Furthermore, the glomerulus contributes to regulating systemic blood pressure and maintaining fluid-electrolyte homeostasis through some proteins, including renin (<xref ref-type="bibr" rid="B1">1</xref>). As the basic functional unit of the kidney, it is mainly composed of terminally differentiated epithelial cells&#x2014;podocytes, which cover the pericytes of the glomerular capillaries&#x2014;mesangial cells (MCs), glomerular endothelial cells (gECs), and other less common cell types. These cells collectively undertake a variety of different functions. Both primary glomerular diseases, which are confined to the glomeruli, and secondary glomerular diseases, resulting from systemic disorders, can cause damage to function and architecture of glomerular cells, leading to hematuria, proteinuria, edema, and decreased glomerular filtration rate (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>In podocytopathies characterized by proteinuria or nephrotic syndrome, foot process effacement (FPE) and foot process simplification represent the earliest morphological manifestations of podocyte injury. Notably, substantial proteinuria may manifest even in the absence of podocyte injury (<xref ref-type="bibr" rid="B4">4</xref>). The reorganization of the actin cytoskeleton is pivotal in the pathogenesis of FPE (<xref ref-type="bibr" rid="B4">4</xref>). Dysregulation among key actin cytoskeleton regulators can directly induce FPF, particularly involving the Rho family of small GTPases, including RhoA, CDC42, and RAC1 (<xref ref-type="bibr" rid="B5">5</xref>). In diabetic nephropathy, the diabetic milieu induces &#x201c;pathological-adaptive&#x201d; alterations in podocytes, characterized by cytoskeletal remodeling, dedifferentiation, apoptosis, and autophagy (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Simultaneously, mesangial cells sustain significant diabetic injury, showing proliferation, hypertrophy, and concomitant upregulation of extracellular matrix protein production (<xref ref-type="bibr" rid="B8">8</xref>). Impairments in the endothelial cells caused by toxins, antibodies, immune cells, or inflammatory cytokines, or deficiencies in endothelial protective factor (such as regulators of complement or angiogenesis), can lead to either acute or chronic kidney injury (<xref ref-type="bibr" rid="B9">9</xref>). Endothelial-to-mesenchymal transition contributes to the pathogenesis of renal fibrosis and the progression of chronic kidney disease by promoting the phenotypic transformation of endothelial cells toward mesenchymal phenotype (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>Although glomerular cells are essential in maintaining normal kidney function and in the development of related diseases, there is still a lack of clear research and systematic description of the characterization changes of mouse glomerular cells under different pathological and physiological conditions. Research in this area urgently requires in-depth exploration to uncover the functional characteristics of glomerular cells under various conditions and their potential roles in kidney diseases, thereby offering more precise targets and strategies for clinical treatment. In recent years, single-cell RNA sequencing (scRNA-seq) technology has fundamentally enhanced our ability to characterize glomerular cells (<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>This study used scRNA-seq to comprehensively characterize the glomerular cell types in healthy mice and four different disease models, each mimicking a renal disease: the nephritis model (lupus nephritis or Goodpasture disease), the adriamycin-induced model (focal segmental glomerulosclerosis), the CD2AP knockout model (sporadic nephrotic syndrome or focal segmental glomerulosclerosis), and the diabetic model (diabetic nephropathy, DN). It successfully depicted the comprehensive transcriptional profiles of all cell types in the glomeruli. This work not only offers a thorough and integrated view at the single-cell level for elucidating the physiological and pathological characteristics of the glomeruli but also provides crucial data for understanding the characteristics of all cell types in the murine glomeruli under various pathological and physiological conditions. Through detailed analysis of the transcriptional spectra of these cells, we have uncovered the role of glomerular cells in kidney diseases, offering new insights for targeted therapies. These discoveries not only deepen our understanding of the pathogenic mechanisms of kidney diseases but also pave the way for the potential development of new treatment strategies and drug targets.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Method</title>
<sec id="s2_1">
<label>2.1</label>
<title>Single-cell data and quality control</title>
<p>The single-cell RNA sequencing data used in this study was downloaded from the Gene Expression Omnibus (GEO) database, specifically from dataset GSE146912. Data processing was performed using Seurat version 4.4.0, which is widely used for single-cell RNA-seq analysis. Quality control (QC) measures were implemented to ensure the reliability of the data. The QC criteria included the requirement that each gene must be expressed in at least 1% of the cells, and the number of genes detected in each cell was constrained to a range of 400 to 7,000. Additionally, cells with a mitochondrial gene percentage greater than 5% and those with a high percentage of red blood cell-related genes (&gt;1%) were excluded to minimize potential sources of contamination or low-quality data.</p>
<p>To further improve data quality, doublets (i.e., events where two or more cells are incorrectly captured as a single cell) were identified and removed using the DoubletFinder (version 2.0.3) algorithm. Subsequent cell clustering was based on these identified variable genes. The identification of differentially expressed genes (DEGs) was performed using the Seurat function FindAllMarkers, which helps in the detection of genes that are uniquely expressed in each cluster of cells. Cluster annotation was carried out by referencing typical cell-type-specific markers in the literature.</p>
<p>To address potential batch effects, which are common in large-scale single-cell datasets, the Harmony algorithm (version 1.2.0) was employed to integrate the data and mitigate these batch effects, ensuring more accurate and robust downstream analysis. This approach ensures high-quality and reliable results for subsequent analyses and interpretations.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Cell communication analysis</title>
<p>In this study, we conducted cell communication analysis using CellChat V1.6.1, with the mouse database selected for the analysis. CellChat is a powerful tool that integrates prior knowledge of ligand-receptor interactions and their cofactors to model the probability of cell communication from single-cell RNA-seq data. The analysis process involves several key steps. First, we created a CellChat object by inputting the normalized data and cell metadata. Then, we set the mouse database in the CellChat object. Next, we preprocessed the expression data to identify overexpressed genes and interactions, which are crucial for subsequent communication inference. After that, we applied the projectData function to smooth the data using protein-protein interaction (PPI) data, enhancing the reliability of communication predictions. Subsequently, we computed the communication probabilities and filtered the interactions based on a minimum cell threshold. Finally, we aggregated the communication network at the pathway level. To assess intergroup differences, we performed differential interaction analysis using the netVisual_diffInteraction function. All visualizations were generated using built-in CellChat functions.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Transcription factor analysis</title>
<p>We conducted transcription factor analysis using pySCENIC V0.12.1, a powerful Python-based tool for inferring gene regulatory networks from single-cell RNA-seq data. The analysis process involves three main steps. First, we constructed a co-expression network of transcription factors and potential target genes using the grn command with the GRNBoost2 algorithm, which identifies regulatory relationships based on gene expression correlations. Next, we refined the network by integrating motif information with the ctx command, using the mm10_10kbp_up_10kbp_down_full_tx_v10_clust.genes_vs_motifs.rankings.feather file as input. This step filters out non-significant interactions and retains only those supported by motif evidence. Finally, we assessed the activity of each regulon across all cells using the aucell command, which provides a quantitative measure of regulon activity in each cell. The visualization process followed the SCENIC (R) tutorial, ensuring a comprehensive presentation of the results.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Pseudotime analysis</title>
<p>We performed pseudotime analysis using Monocle2 V2.26.0. The analysis workflow involved several key steps. First, we identified differentially expressed genes across clusters using the differentialGeneTest function with a full model formula that included cluster information. The top 1000 genes identified from this analysis were used to filter the dataset with the setOrderingFilter function. Next, we applied dimensionality reduction using the reduceDimension function with the DDRTree method, which is the default in Monocle2 and helps visualize the data in a low-dimensional space. Finally, cells were ordered along the inferred trajectory using the orderCells function. Additionally, genes that varied along the pseudotime trajectory were also identified using differentialGeneTest, and their expression patterns were visualized with the corresponding Monocle2 functions.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Gene set enrichment analysis</title>
<p>In this study, we employed the clusterProfiler package to conduct Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. For each cluster, the top 50 differentially expressed genes were selected as input for enrichment analysis. The enrichGO function was used to categorize genes into biological process (BP), molecular function (MF), and cellular component (CC), providing insights into their functional roles. Meanwhile, the enrichKEGG function identified significantly enriched signaling pathways associated with each cluster. This approach allowed us to systematically explore the biological significance of each cluster, uncovering potential functional pathways and molecular mechanisms involved in the dataset.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Subcluster analysis</title>
<p>For subcluster identification, relevant cell types were extracted, followed by processing similar to the standard single-cell analysis workflow, except that no additional quality control (QC) was performed. The analysis was conducted using Seurat, following its standard pipeline. Specifically, NormalizeData(normalization.method = &#x201c;LogNormalize&#x201d;) was applied to normalize gene expression, and FindVariableFeatures(selection.method = &#x201c;vst&#x201d;, nfeatures = 2000) was used to identify highly variable genes. The ScaleData function was then applied to the highly variable genes identified previously, to remove unwanted sources of variation.</p>
<p>RunPCA(features = VariableFeatures(object)) was performed for dimensionality reduction, followed by batch effect correction using the Harmony algorithm. FindNeighbors(dims = 1:30, reduction = &#x201c;harmony&#x201d;) was then used to construct the nearest-neighbor graph. For clustering, FindClusters was run iteratively with the resolution parameter ranging from 0.1 to 1 to explore different clustering granularities. The optimal number of clusters was determined using the clustree package, which visualizes clustering results across different resolutions to aid in selecting an appropriate resolution value.</p>
<p>RunUMAP and RunTSNE were used for visualization, and marker genes were identified using FindAllMarkers with default parameters to annotate subclusters based on known cell type markers.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Immunofluorescence</title>
<p>The paraffin-embedded sections were prepared for immunofluorescence. Antigen retrieval for the paraffin-embedded sections was conducted using high-temperature pressure in Tris-EDTA buffer (pH 9.0). Tissue sections were blocked with goat serum (Biosharp, BL1097A) and incubated overnight with primary antibodies (S100a8, R&amp;D, MAB3059; Wilms Tumor 1, Immunoway, YM6533). Fluorescent secondary antibodies (Goat Anti-Rat IgG H&amp;L, Abcam, Cat# ab150159; Goat anti-Mouse IgG (H+L), Invitrogen, Cat#A11001) were incubated for 1 hour. Nuclear staining was performed using DAPI (Biosharp, BL120A). Images were captured using a laser scanning confocal microscope.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Construction of mouse glomerular cell atlas and analysis of expression characteristics of pathogenic genes of kidney disease</title>
<p>To explore the changes in specific gene expression in mouse glomerular cells under differentpathological and physiological backgrounds, we intentionally included mice of different ages (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table 1</bold></xref>), with different disease backgrounds, and at different disease durations for a comprehensive and integrated analysis of the mouse glomerulus (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>). We integrated the enriched single-cell transcriptomic sequencing data (GSE146912) of glomeruli and conducted strict quality control and batch effect correction (Method). Through unsupervised clustering, we obtained 29 subpopulations (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>). Utilizing classical kidney cell markers (<xref ref-type="supplementary-material" rid="SM2"><bold>Supplementary Table 2</bold></xref>), we identified and characterized the kidney cell subpopulations predominantly composed of glomerular cells, including podocytes (PODs), mesangial cells (MCs), endothelial cells (gECs), and parietal epithelial cells (PECs) (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1C</bold></xref>). Different from other kidney single-cell omics data (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>), this dataset had captured a certain number of glomerular-related cell subsets (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>), which had provided the possibility for subsequent analysis.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Construction of mouse glomerular cell atlas and analysis of expression characteristics of pathogenic genes of kidney disease. <bold>(A)</bold> The schematic diagram of this research. <bold>(B)</bold> UMAP of 74,185 glomerular cells. Mes, mesangial Cell; POD, podocyte; gEC, Glomerular endothelial cell; EC, endothelial cell; VSMC, vascular smooth muscle cell; Mac, macrophage; TEC, tubular epithelial cells; PEC, parietal epithelial cell; Ren, renin cell; Pro, proliferating; T, T cell; Fib, fibroblast; Neu, Neutrophil. <bold>(C)</bold> Dot plot of expression of cell type-specific marker genes for each glomerular cell subset. The size of each dot indicates the percentage of cells expressing the marker gene, while the color intensity reflects the average expression level of the marker gene. <bold>(D)</bold> Heatmap of the expression profiles of pathogenic single genes in common kidney diseases across different subgroups.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1763345-g001.tif">
<alt-text content-type="machine-generated">Panel A displays groups of mice used for single-cell RNA sequencing studies of the glomerulus, with illustrations and experimental conditions. Panel B shows a UMAP plot of 74,185 single cell clusters colored and labeled by cell type. Panel C presents a dot plot of cell-type-specific gene expression, with gene names on the y-axis and cell type clusters on the x-axis. Panel D shows a heatmap comparing gene expression patterns across different kidney diseases, with disease labels (FSGS, DN, LN, IgAN) on the left and gene names on the right.</alt-text>
</graphic></fig>
<p>We systematically profiled the expression of susceptibility genes identified through genome-wide association studies (GWAS) for major kidney diseases (focal segmental glomerulosclerosis-FSGS, diabetic nephropathy-DN, lupus nephritis-LN, immunoglobulin A nephropathy-IgAN) across diverse renal cell subtypes, and delineated their cell type&#x2013;specific enrichment patterns (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1D</bold></xref>). Genes linked to FSGS were highly expressed primarily within glomerular cells, notably PODs, PECs, and MCs, but exhibited minimal influence on gECs, extraglomerular endothelial cells, or various immune cells. Conversely, DN-associated genes were broadly expressed across diverse renal cell subtypes. For LN, the pathogenic genes were not prominently expressed in PODs but were predominantly enriched in MCs and MAC-related subsets. In contrast, IgAN-associated genes were widely active in gECs, extraglomerular endothelial cells, and immune cells, yet showed limited expression in other intrinsic glomerular cells.</p>
<p>Notably, we identified a high expression of multiple disease-associated molecules in Cluster 17 (pro_EC). This subpopulation expresses gEC markers (<italic>Sost</italic>, <italic>Ehd3</italic>) along with characteristic proliferation-related molecules (<italic>Top2a</italic>, <italic>Stmn1</italic>). These results suggest the existence of a distinct proliferative gEC population within the glomerulus, which may play a pivotal role in disease pathogenesis.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Distinct molecular signatures of podocyte injury across disease contexts</title>
<p>Given the critical role of POD and PEC injury in proteinuria pathogenesis (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), we performed an integrated re-clustering analysis of these populations, which identified 13 distinct subclusters (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>). Clusters 8 and 10 both expressed established PEC markers (<italic>Igfbp6</italic>, <italic>Ptgis</italic>, <italic>Pla2g7</italic> and <italic>Dkk3</italic>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>). Cluster 8 was designated as PEC_1 based on its high expression of AP-1-related molecules (<italic>Junb</italic>, <italic>Jun</italic>, <italic>Fos</italic> and <italic>Fosb</italic>). In contrast, Cluster 10, characterized by elevated expression of <italic>Cp</italic>, <italic>Pcp4</italic>, <italic>Cdh16</italic>, <italic>Fxyd1</italic>, <italic>C3</italic>, <italic>Pax8</italic>, <italic>Vcam1</italic>, and <italic>Cd9</italic>, was designated PEC_2. Notably, while PEC_1 contained cells derived from both healthy and diseased mice, the PEC_2 population was predominantly contributed by the disease group (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2C</bold></xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Distinct molecular signatures of podocyte injury across disease contexts. <bold>(A)</bold> UMAP of 11,637 podocytes. <bold>(B)</bold> Dot plot of expression of cell type-specific marker genes for each podocyte subset. The size of each dot indicates the percentage of cells expressing the marker gene, while the color intensity reflects the average expression level of the marker gene. <bold>(C)</bold> Bar chart of podocyte subset proportions across different animal models. <bold>(D)</bold> Heatmap of characteristic transcription factors in different podocyte subsets. <bold>(E, F)</bold> Bar chart of GO enrichment analysis for different podocyte subsets.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1763345-g002.tif">
<alt-text content-type="machine-generated">Panel A presents a UMAP plot visualizing 12 podocyte subclusters. Panel B shows a dot plot of gene expression levels across these clusters. Panel C contains a horizontal bar graph of cluster composition by experimental group. Panel D presents a heatmap of regulon activity among cell types and conditions. Panels E, F, and G display bar graphs of gene ontology enrichment analysis for Pod_Injury_1, Pod_ob, and Pod_ADR, respectively.</alt-text>
</graphic></fig>
<p>Distinct injured podocyte subpopulations emerge across disease models (<xref ref-type="fig" rid="f2"><bold>Figures&#xa0;2A, B</bold></xref>). These clusters exhibit unique molecular signatures (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>), disease origins (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2C</bold></xref>), transcription factor activities (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2D</bold></xref>), and functional enrichments (<xref ref-type="fig" rid="f2"><bold>Figures&#xa0;2E&#x2013;G</bold></xref>). POD_Injury_1, present across multiple disease models (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2C</bold></xref>), highly expresses <italic>Tagln</italic>, <italic>Cxcl1</italic>, <italic>Crct1</italic>, <italic>Angptl7</italic>, <italic>Tgfb2</italic>, and <italic>Flna</italic> (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>), suggesting a common injury response signature shared among different nephropathies. In contrast, Cluster 2 exhibits high expression of <italic>Endou</italic>, <italic>Cd200</italic>, <italic>Lgmn</italic>, <italic>Il18</italic>, <italic>Dmpk</italic>, and <italic>Spon2</italic> (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>) and originates almost exclusively from <italic>ob/ob</italic> mice (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2C</bold></xref>), prompting its annotation as POD_ob. Similarly, Cluster 11, predominantly originating from ADR-treated mice, was designated POD_ADR based on elevated expression of <italic>Selenbp1</italic>, <italic>Lpar1</italic>, <italic>S100a8</italic>, <italic>S100a9</italic>, and <italic>Sult1a1</italic>. Transcription factor analysis revealed that POD_ob specifically expresses <italic>Churc1</italic>, <italic>Sp2</italic>, <italic>Dbp</italic>, <italic>Foxc2</italic>, <italic>Mafb</italic>, and <italic>E2f1</italic>, while POD_Injury_1 and POD_Injury_2 both upregulate <italic>Bcl3</italic>, <italic>Rela</italic>, <italic>Fosl1</italic> and <italic>Nfkb2</italic>. POD_ADR is characterized by high expression of <italic>Cebpd</italic> (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2D</bold></xref>). GO analysis indicated that POD_Injury_1 (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2E</bold></xref>) and POD_ob (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2F</bold></xref>) are both enriched in terms related to cytoskeleton and actin filament organization. POD_ADR, however, is primarily involved in intracellular signaling, protein transport and secretion, smooth muscle cell migration, and apoptotic signaling pathways (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2G</bold></xref>).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Shared molecular signature of podocyte injury across disease contexts</title>
<p>To identify common injury mechanisms, we compared the transcriptional profiles of podocyte subclusters between disease and control groups, quantifying differentially expressed genes (DEGs). A substantial number of DEGs were identified in POD_AP1 across different age groups and at the 5-day nephritis time point. Additionally, POD_1, POD_2, and POD_3 also exhibited numerous DEGs under conditions of aging, diabetes, and nephritis (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3A</bold></xref>). Notably, POD_1&#x2014;a major constituent of the podocyte population&#x2014;significantly downregulated AP-1-related molecules (<italic>Fos</italic>, <italic>Junb</italic>, <italic>Jun</italic>, <italic>Fosb</italic>, <italic>Atf3</italic>) with advancing age. In the nephritic state, <italic>Spp1</italic> and <italic>Cebpb</italic> was markedly upregulated (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3B</bold></xref>). Pseudotime analysis of podocyte subclusters distributed them across five distinct states, with a majority of injury-associated subclusters coalescing in State 5 (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3C&#x2013;E</bold></xref>). GO analysis revealed that State 5 is primarily associated with cell&#x2013;matrix interactions, actin filament assembly and organization, wound healing, morphogenesis of cardiac and muscle tissue, positive regulation of T-cell activation and positive regulation of leukocyte&#x2013;cell adhesion (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3F</bold></xref>). Key injury-related genes, including <italic>Tagln</italic>, <italic>Cald1</italic>, <italic>Tagln2</italic>, <italic>Gpx3</italic>, <italic>Press23</italic>, and <italic>Lgals1</italic>, were also predominantly highly expressed in this state (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3G</bold></xref>). These characteristics suggest that State 5 likely represents a characteristic injury or repair state, involved in podocyte response, remodeling, and immunomodulatory processes following damage. Notably, the immunofluorescence staining of renal tissues confirmed the co-expression of Wt1 and S100a8 in ADR mice, demonstrating that some podocytes highly express S100a8 in this disease model (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3H</bold></xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Shared molecular signature of podocyte injury across disease contexts. <bold>(A)</bold> Heatmap of the number of differentially expressed genes (DEGs) between different animal models and the control group. <bold>(B)</bold> Volcano plots of DEGs comparing different animal models to the control group (aging and nephritis). <bold>(C)</bold> Pseudotime trajectory analysis performed using monocle2, with different colors representing different pseudotime values. <bold>(D)</bold> Pseudotime trajectory analysis performed using monocle2, with different colors representing different cell states. <bold>(E)</bold> Proportion of podocytes from different animal models in each state of the pseudotime analysis. <bold>(F)</bold> Bar chart showing the results of GO enrichment analysis for state 5. <bold>(G)</bold> Expression patterns of key genes along the pseudotime axis in the pseudotime analysis. <bold>(H)</bold> Representative IF image of S100a8-positive podocytes in the healthy control (left) and ADR model (right) groups. Scale bar = 10 &#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1763345-g003.tif">
<alt-text content-type="machine-generated">Panel A shows a heatmap of gene expression values across various podocyte and glomerular cell populations, with blue indicating lower and red higher expression. Panel B contains two volcano plots highlighting differentially expressed genes, with key genes labeled in red. Panel C depicts a pseudotime trajectory plot, color-coding cells based on pseudotime. Panel D shows a similar trajectory colored by five identified states. Panel E visualizes a stacked bar plot of cell state proportions across conditions. Panel F presents a bar graph of enriched gene ontology terms with associated genes and significance. Panel G displays four UMAP plots showing the expression patterns of specific genes across cell states. Panel H contains immunofluorescence images comparing Wt1 and S100a8 protein expression in control and ADR samples, with nuclei counterstained by DAPI.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Molecular signature of mesangial cell injury with a focus on diabetic nephropathy</title>
<p>Mesangial cells (MCs) are crucial for maintaining glomerular structural integrity, regulating filtration rate, synthesizing or degrading extracellular matrix (ECM), and producing various cytokines and bioactive molecules (<xref ref-type="bibr" rid="B19">19</xref>). We performed reclustering analysis on MCs, identifying 13 distinct subclusters (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4A</bold></xref>), which were annotated based on their characteristic gene expression profiles (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4B</bold></xref>). Among these, we focused on cluster 1, annotated as Mes_Injury, which was predominantly derived from multiple disease groups (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4C</bold></xref>). This subpopulation highly expressed <italic>Cxcl1</italic>, <italic>Egr1</italic>, <italic>Hspa1b</italic>, <italic>Socs3</italic>, and <italic>Dnaib1</italic> (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4D</bold></xref>). Notably, we identified several disease-specific MC subclusters&#x2014;clusters 3, 11, and 12&#x2014;that were markedly expanded in <italic>ob/ob</italic> mice (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4C</bold></xref>). Specifically, Mes_ob_1 (cluster 3) exhibited a transcriptome distinct from other MCs and appeared as an outlier in UMAP visualization (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4A</bold></xref>). It was characterized by high expression of <italic>Aldh1a2</italic>, <italic>Thbs1</italic>, <italic>Fbln5</italic>, <italic>Cdh11</italic>, and <italic>Loxl2</italic> (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4B</bold></xref>). Transcription factor analysis revealed that Mes_Injury highly expressed <italic>Fos</italic>, <italic>Junb</italic>, <italic>Xbp1</italic>, and <italic>Cebpb</italic>, while all <italic>ob/ob</italic>-derived MCs shared high expression of <italic>Dbp</italic> and <italic>Prrx2</italic> (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4D</bold></xref>). Mes_ob_1 uniquely expressed <italic>Mbd2</italic>, <italic>Spi1</italic>, and <italic>Pura</italic> (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4E</bold></xref>). Of translational relevance, <italic>Prrx2</italic> is involved in development, tissue repair, and epithelial&#x2013;mesenchymal transition (EMT), regulating ECM remodeling and cell migration (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). <italic>Spi1</italic>, primarily expressed in the immune system, is a key regulator of hematopoiesis and immune responses (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Functionally, GO enrichment analysis indicated that Mes_Injury is primarily associated with intracellular signaling regulation and stress responses (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4F</bold></xref>), whereas Mes_ob_1 is more enriched in processes related to cell migration, tissue repair, and cell&#x2013;matrix interactions (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4G</bold></xref>). Pseudotime trajectory analysis of all MC subclusters (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4H</bold></xref>) showed that <italic>ob/ob</italic>-derived MCs were concentrated in State 3 (<xref ref-type="fig" rid="f4"><bold>Figures&#xa0;4I, J</bold></xref>), where enriched genes were functionally linked to antigen presentation, immune response, regulation of epithelial cell proliferation, and negative regulation of cell projection organization (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4K</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Molecular signature of mesangial cell injury with a focus on diabetic nephropathy <bold>(A)</bold> UMAP of 21,174 Mesangial cells. <bold>(B)</bold> Heatmap of expression of cell type-specific marker genes for each mesangial cell subset. The size of each dot indicates the percentage of cells expressing the marker gene, while the color intensity reflects the average expression level of the marker gene. <bold>(C)</bold> Bar chart of mesangial cell subset proportions across different animal models. <bold>(D)</bold> Heatmap of characteristic transcription factors in different mesangial cell subsets. <bold>(E)</bold> The characteristic transcription factors of Mes_ob_1. <bold>(F, G)</bold> Bar chart of GO enrichment analysis for different mesangial cell subsets. <bold>(H)</bold> Pseudotime trajectory analysis performed using monocle2, with different colors representing different pseudotime values. <bold>(I)</bold> Pseudotime trajectory analysis performed using monocle2, with different colors representing different cell states. <bold>(J)</bold> Proportion of podocytes from different animal models in each state of the pseudotime analysis. <bold>(K)</bold> Bar chart showing the results of GO enrichment analysis for state 4.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1763345-g004.tif">
<alt-text content-type="machine-generated">Composite scientific figure presenting mesangial cell single-cell RNA sequencing analysis, including a UMAP plot for clustering (A), heatmap of gene expression (B), sample composition by cluster (C), expression pattern heatmap (D), ranked gene expression plot (E), bar graphs of gene ontology enrichment for specific clusters (F, G, K), trajectory analysis plots (H, I), and bar plots of sample distribution across cell states (J).</alt-text>
</graphic></fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>A Shared glomerular endothelial cell injury subpopulation is induced across diverse disease models</title>
<p>Glomerular endothelial cells (gECs) are essential for maintaining the integrity of the filtration barrier, regulating molecular exchange, balancing coagulation and anticoagulation, and providing structural support (<xref ref-type="bibr" rid="B9">9</xref>). Their injury contributes to increased permeability (leading to hematuria and proteinuria) and microthrombosis, thereby accelerating kidney disease progression (<xref ref-type="bibr" rid="B9">9</xref>). We performed reclustering of gECs, identifying 18 subclusters that included 9 distinct subpopulations with unique transcriptional profiles (<xref ref-type="fig" rid="f5"><bold>Figures&#xa0;5A, B</bold></xref>). Notably, gEC heterogeneity was not primarily driven by specific disease contexts (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5A</bold></xref>). However, cluster 9 emerged as an exception, being predominantly derived from multiple disease groups (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5C</bold></xref>). We annotated cluster 9 as gEC_Injury, identifying it as a potential common injury-specific subpopulation (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5B</bold></xref>). The gEC_Injury subpopulation was characterized by high expression of <italic>Apln</italic>, <italic>Mir147</italic>, <italic>Pgf</italic>, <italic>Actn1</italic>, <italic>Ercc</italic> and <italic>Procr</italic> (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5B</bold></xref>). Key transcription factors defining this cluster included <italic>Fosl</italic>, <italic>Tead4</italic>, and <italic>Relb</italic> (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5D</bold></xref>), which are known regulators of cell proliferation, migration, immune response, and tissue repair (<xref ref-type="bibr" rid="B24">24</xref>&#x2013;<xref ref-type="bibr" rid="B26">26</xref>). Consistent with this molecular signature, GO analysis indicated that gEC_Injury is functionally enriched in processes related to cell migration, cytoskeletal regulation, immune response, as well as angiogenesis and vascular development (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5E</bold></xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p><bold>(A)</bold> shared glomerular endothelial cell injury subpopulation is induced across diverse disease models. <bold>(A)</bold> UMAP of 36,759 glomerular endothelial cells. <bold>(B)</bold> Heatmap of expression of cell type-specific marker genes for each glomerular endothelial cell subset. The size of each dot indicates the percentage of cells expressing the marker gene, while the color intensity reflects the average expression level of the marker gene. <bold>(C)</bold> Bar chart of glomerular endothelial cell subset proportions across different animal models. <bold>(D)</bold> Heatmap of characteristic transcription factors in different glomerular endothelial cell subsets. <bold>(E)</bold> The characteristic transcription factors of gEC_injury_1.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1763345-g005.tif">
<alt-text content-type="machine-generated">Composite scientific figure with five panels: Panel A shows a UMAP plot of glomerular endothelial cells clustered into 18 subpopulations, each colored and labeled. Panel B displays a heatmap of gene expression profiles across cell clusters. Panel C illustrates a stacked bar plot of cell cluster composition across experimental conditions. Panel D presents a heatmap showing transcription factor activity by cell type. Panel E contains a horizontal bar graph of gene ontology enrichment for gEC_injury_1, highlighting terms related to cell migration and cytoskeleton organization.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Widespread alterations in glomerular endothelial cell subpopulations induced by diverse disease models</title>
<p>Transcriptomic analysis revealed substantial differential gene expression in gEC_1, gEC_2, gEC_3, gEC_4, and gEC_6 under nephritis and ADR conditions, with a predominant pattern of transcriptional upregulation (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6A</bold></xref>). Among these, gEC_1 and gEC_2 exhibited the most pronounced changes (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6A</bold></xref>). Disease-specific responses were observed for these two subpopulations: gEC_1 significantly upregulated <italic>Spp1</italic>, <italic>Sparc</italic>, and <italic>Mgp</italic> in the 5-day nephritis model (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6B</bold></xref>), whereas gEC_2 was characterized by elevated expression of <italic>Lrg1</italic>, <italic>S100a8</italic>, <italic>Fabp4</italic>, <italic>Serpine2</italic>, and <italic>Ch25h</italic> in the ADR model (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6C</bold></xref>). Pseudotime trajectory analysis (<xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6D&#x2013;J</bold></xref>) further delineated injury-associated states. State 9 was predominantly populated by cells from disease groups and served as the primary distribution zone for the gEC_Injury subpopulation (<xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6E&#x2013;G</bold></xref>). State 10 was also largely composed of disease-derived cells, with the ADR model being the major contributor (<xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6E&#x2013;G</bold></xref>). Functional characterization showed that State 9 was significantly enriched for biological processes related to collagen synthesis and metabolism, inflammatory responses, angiogenesis, and responses to bacterium-derived molecules (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6H</bold></xref>). In contrast, State 10 was primarily associated with cellular responses to interleukin-17 and chemokines, chemokine-mediated signaling pathways, detoxification of inorganic compounds, and responses to metal ions and inorganic substances (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6I</bold></xref>). Furthermore, key genes involved in cellular stress, immune response, proliferation, and differentiation&#x2014;including <italic>Socs3</italic>, <italic>Nfkbia</italic>, <italic>Atf3</italic>, and <italic>Icam1</italic>&#x2014;were highly expressed in both State 9 and State 10 (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6J</bold></xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Widespread alterations in glomerular endothelial cell subpopulations induced by diverse disease models, <bold>(A)</bold> Heatmap of the number of differentially expressed genes (DEGs) between different animal models and the control group. <bold>(B)</bold> Volcano plots of DEGs comparing nephritis_d5 animal models to the control group. <bold>(C)</bold> Volcano plots of DEGs comparing ADR animal models to the control group. <bold>(D)</bold> Pseudotime trajectory analysis performed using monocle2, with different colors representing different pseudotime values. <bold>(E)</bold> Pseudotime trajectory analysis performed using monocle2, with different colors representing different cell states. <bold>(F)</bold> Proportion of podocytes from different animal models in each state of the pseudotime analysis. <bold>(G)</bold> Proportion of podocytes from glomerular endothelial cell subsets in each state of the pseudotime analysis. <bold>(H)</bold> Bar chart showing the results of GO enrichment analysis for state 9. <bold>(I)</bold> Bar chart showing the results of GO enrichment analysis for state 10. <bold>(J)</bold> Expression patterns of key genes along the pseudotime axis in the pseudotime analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1763345-g006.tif">
<alt-text content-type="machine-generated">Heatmap (A) displays gene expression counts across different endothelial cell types and experimental conditions. Volcano plots (B, C) show differentially expressed genes in nephritis and ADR conditions, highlighting up- and downregulated genes. Trajectory analyses (D, E) illustrate cell pseudotime and clustering, with color gradients for pseudotime and state. Barplots (F, G) describe cell proportion ratios by sample and cell type for each state. Bar graphs (H, I) summarize top enriched pathways for states 9 and 10. Panel (J) shows feature plots of gene expression for Socs3, Nfkbia, Atf3, and Icam1 along trajectories.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Specific ligand&#x2013;receptor interactions in injury-related cell subsets</title>
<p>We analyzed the interactions between glomerular cell subsets and other cell types under disease conditions (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7A</bold></xref>) and found that mesangial cells exhibited particularly prominent ligand&#x2013;receptor relationships with other cell subpopulations (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7B</bold></xref>). Notably, we observed that VISFATIN-mediated ligand&#x2013;receptor interactions were primarily identified between Mes_injury and Pod_injury_1 subsets (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7C</bold></xref>). This suggested that extracellular NAMPT derived from mesangial cells may directly or indirectly bind to and activate Toll-like receptor 4 (TLR4) on podocytes. Elevated Visfatin levels are known to promote chronic inflammation via the TLR4/NF-&#x3ba;B pathway (<xref ref-type="bibr" rid="B27">27</xref>). Consistent with our findings (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7D</bold></xref>), prior studies have reported that mesangial cells may upregulate Cxcl1 expression upon injury (<xref ref-type="bibr" rid="B16">16</xref>). Furthermore, we detected high Cxcl1 expression in other injured podocyte subsets. This may represent a shared mechanism by which mesangial cells and podocytes collectively facilitate the infiltration of CXCR2-high neutrophils in glomerular diseases. Injured podocytes may also recruit macrophages and neutrophils via CADM, CXCL, and MIF pathways (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7E</bold></xref>). Among glomerular cell types, Mif was predominantly upregulated in Pod_injury_1 under injury conditions, while its receptors&#x2014;Cd74, Cd44, and Cxcr4&#x2014;were highly expressed in macrophages, neutrophils, and Pod_Und subpopulations (<xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7F</bold></xref>). Existing evidence supports a key role for MIF signaling in inflammatory recruitment (<xref ref-type="bibr" rid="B28">28</xref>). Recent studies suggest that MIF&#x2013;CD44 interactions may contribute to parietal epithelial cell injury and the development of focal segmental glomerulosclerosis (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B29">29</xref>). Our results indicated that this may represent a broad mechanism underlying glomerular inflammatory recruitment following podocyte injury across multiple disease contexts.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Specific ligand&#x2013;receptor interactions in injury-related cell subsets. <bold>(A)</bold> Heat map of ligand&#x2013;receptor interaction network between glomerular cell subsets and other cell types under disease conditions. <bold>(B)</bold> Quantification of ligand&#x2013;receptor relationship prominence among glomerular cell subsets <bold>(C)</bold> Chord diagram showing VISFATIN-mediated ligand&#x2013;receptor interactions between glomerular cell subsets and other cell subpopulations. <bold>(D)</bold> Violin plot displaying Cxcl1/CXCR2 expression levels in glomerular subsets and other cell subpopulations under injury conditions. <bold>(E)</bold> Heat map of CADM, CXCL, and MIF ligand&#x2013;receptor pathways involved in macrophage and neutrophil recruitment, illustrating the receivers, mediators, and influencer among glomerular subsets and other cell subpopulations. <bold>(F)</bold> Violin plot showing the expression of Mif, Ackr3, Cd74, Cd44, and Cxcr4 in glomerular cell subsets and other cell types under injury conditions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1763345-g007.tif">
<alt-text content-type="machine-generated">Panel A contains two heatmaps comparing outgoing and incoming cell signaling patterns across various gene families and cell types, with axes labeled by gene and cell type names. Panel B presents a scatter plot depicting incoming versus outgoing interaction strengths, where point sizes correspond to interaction counts and points are colored by cell group. Panel C displays a chord diagram illustrating intercellular communication between identified cell populations, connected by colored lines. Panel D features violin plots comparing gene expression levels for Cxcl2 and Cxcl1 across cell types. Panel E shows additional heatmaps for selected signaling pathways between cell types, including MIF and WNT. Panel F presents violin plots of gene expression for Mif, Ackr3, Cd74, Cd44, and Cxcr4 across cell types.</alt-text>
</graphic></fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>With an increasing number of kidney diseases found to have genetic factors, and the gradual identification of susceptibility genes for diseases such as FSGS, IgAN, and DN, there has been a strong interest in exploring the molecular mechanisms of kidney diseases (<xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>). In-depth analysis of the transcriptional profile characteristics of glomerular cells under different pathological and physiological conditions at the molecular level is expected to completely transform traditional diagnostic strategies and open up new avenues for the treatment of kidney diseases. Therefore, we used single-cell RNA sequencing (scRNA-seq) to characterize the cells of the glomerulus and further identify characteristic changes in cell states under pathological conditions.Integrating insights from genomics, we discovered that susceptibility genes for different glomerulopathies are enriched in distinct cell types. Specifically, FSGS-associated genes are predominantly highly expressed in podocytes and mesangial cells, whereas DN-associated genes lack such cell type-specific enrichment. These findings suggest that the primary target&#x2014;or the initially injured cell type&#x2014;may differ significantly across various glomerular diseases.</p>
<p>To date, gene expression in the glomerulus has been examined almost exclusively in cell populations rather than at the single-cell level. Therefore, it is not yet clear whether there is cellular heterogeneity within the glomerular cells. To address this fundamental question, we performed re-clustering analysis on 11,637 podocytes, 21,174 glomerular endothelial cells, and 36,759 mesangial cells, systematically delineating the molecular alterations in glomerular cell subpopulations under disease conditions. Notably, we identified both shared and disease-specific molecular signatures across different pathological contexts. Within podocytes, a shared injury subpopulation emerged, characterized by its association with actin cytoskeleton organization and high expression of <italic>Tagln</italic>, <italic>Cxcl1</italic>, <italic>Crct1</italic>, <italic>Angptl7</italic>, <italic>Tgfb2</italic>, and <italic>Flna</italic>. Transgelin, encoded by <italic>Tagln</italic>, is an actin-binding protein that regulates actin polymerization, bundling, or cross-linking (<xref ref-type="bibr" rid="B33">33</xref>). Previous studies have shown that asparagine endopeptidase, Cyclosporine A, and the Smad3 inhibitor SIS3 can protect podocytes and reduce proteinuria by inhibiting or cleaving transgelin (<xref ref-type="bibr" rid="B34">34</xref>&#x2013;<xref ref-type="bibr" rid="B36">36</xref>). Additionally, LPS and serum albumin (SA) significantly upregulate <italic>CXCL1</italic> expression in podocytes (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). In contrast, disease-specific podocyte subpopulations were also observed: an ADR-induced cluster highly expressing <italic>Selenbp1</italic>, <italic>Lpar1</italic>, <italic>S100a8</italic>, <italic>S100a9</italic>, and <italic>Sult1a1</italic>, and an <italic>ob/ob</italic>-specific cluster enriched in <italic>Endou</italic>, <italic>Cd200</italic>, <italic>Lgmn</italic>, <italic>Il18</italic>, <italic>Dmpk</italic>, and <italic>Spon2</italic>. Podocytes are terminally differentiated epithelial cells. S100a8 typically forms a heterodimer with S100a9, known as calprotectin (<xref ref-type="bibr" rid="B39">39</xref>). To provide a solid cellular context for interpreting those findings, we focused validation on WT1-positive podocytes due to its specificity and conservation. The co-expression of S100a8 in WT1-positive cells directly demonstrates that these podocytes themselves are in an activated or injured state. The S100a8/S100a9 heterodimer can be released into the extracellular space, where it binds to receptors such as TLR4 and RAGE, activating neighboring podocytes, tubular epithelial cells, and infiltrating immune cells. The transcription factor (TF) activities also differed markedly among these subpopulations. For instance, injured podocytes exhibited activation of TFs such as <italic>Bcl3</italic>, <italic>Rela</italic>, <italic>Fosl1</italic>, and <italic>Nfkb2</italic>, providing deeper insight into the upstream regulatory events during podocyte injury. The AP-1 pathway appears to play a dual, context-dependent role in podocytes: while it is downregulated during maturation (as seen in 12-week-old versus 3-week-old mice (<xref ref-type="bibr" rid="B15">15</xref>)) and may support a differentiated state at low homeostatic levels, its sustained, high-level activation in the disease-associated POD-AP1 subpopulation is strongly linked to dedifferentiation and injury.</p>
<p>Under diabetic conditions, mesangial cells undergo distinct transcriptional reprogramming and give rise to a unique subpopulation characterized by high expression of <italic>Aldh1a2</italic>, <italic>Thbs1</italic>, <italic>Fbln5</italic>, <italic>Cdh11</italic>, and <italic>Loxl2</italic>. ALDH1A2, a rate-limiting enzyme in retinoic acid (RA) synthesis, is essential for kidney development (<xref ref-type="bibr" rid="B40">40</xref>) and catalyzes the oxidation of retinol to RA (<xref ref-type="bibr" rid="B41">41</xref>). Dysregulation of RA metabolism is considered a key pathogenic factor in diabetic nephropathy(DN) (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). D-site-binding protein (DBP), encoded by <italic>DBP</italic>, regulates retinol metabolism and TGF-&#x3b2;1 signaling (<xref ref-type="bibr" rid="B44">44</xref>). Our data indicate that <italic>DBP</italic> is highly activated in this specific mesangial subpopulation in DN, suggesting that DBP may drive retinol metabolic dysregulation, as reflected by the elevated <italic>Aldh1a2</italic> expression. THBS1, encoded by <italic>Thbs1</italic>, interacts with multiple extracellular matrix (ECM) components&#x2014;including collagen V and VII, fibrinogen, jagged1, laminin, MMP-2, MMP-9, TGF-&#x3b2;, CD36, and von Willebrand factor&#x2014;all of which are closely associated with mesangial ECM homeostasis (<xref ref-type="bibr" rid="B45">45</xref>). <italic>Thbs1</italic> has been identified as a hub gene in DN mesangial cells (<xref ref-type="bibr" rid="B46">46</xref>). Furthermore, <italic>Fbln5</italic>, <italic>CDH11</italic>, and <italic>Loxl2</italic> are all strongly linked to ECM regulation and fibrotic processes (<xref ref-type="bibr" rid="B47">47</xref>&#x2013;<xref ref-type="bibr" rid="B50">50</xref>). We also observed activation of the transcription factor <italic>Prrx2</italic> in DN mesangial cells, which may further reinforce TGF-&#x3b2;&#x2013;mediated fibrotic signaling. Together, these findings indicate that mesangial cells in DN acquire a pronounced pro-fibrotic, matrix-secretory phenotype. In addition, consistent with previous reports, we confirmed that injured mesangial cells highly express <italic>Cxcl1</italic> (<xref ref-type="bibr" rid="B16">16</xref>). Pseudotime analysis further revealed that mesangial cells from ob/ob mice are enriched in antigen presentation-related functions. These results imply that in diseased states, mesangial cells may adopt immunomodulatory properties and engage in active crosstalk with immune cells.</p>
<p>In contrast to podocytes and mesangial cells, our analysis did not reveal disease-specific glomerular endothelial cell (gEC) subpopulations across different pathological models. Instead, gECs exhibited a common injury response, characterized by a shared subpopulation with elevated expression of <italic>Apln</italic>, <italic>Mir147</italic>, <italic>Pgf</italic>, <italic>Actn1</italic>, <italic>Ercc1</italic>, and <italic>Procr</italic>. Apelin, encoded by <italic>Apln</italic>, is an endogenous secreted peptide that binds to the orphan receptor APJ (APLNR) and participates in vasodilation, blood pressure regulation, cardiac contractility, and energy metabolism (<xref ref-type="bibr" rid="B51">51</xref>). ACTN1, an actin-crosslinking protein, serves as a key component of the cytoskeleton and contractile apparatus in cells (<xref ref-type="bibr" rid="B52">52</xref>). The upregulation of actin filament-related genes in endothelial cells often represents an adaptive response to mechanical, chemical, or inflammatory stimuli. This response may serve protective roles&#x2014;such as reinforcing barrier function or promoting angiogenesis&#x2014;but may also precede or drive pathological processes, including Endothelial-to-Mesenchymal Transition and vascular stiffening (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>).</p>
<p>Our study has several limitations. First, our analysis was confined to four distinct disease models and healthy controls and did not include secondary glomerulopathies such as ANCA-Associated Glomerulonephritis. Incorporating a broader spectrum of disease models such as membranous nephropathy and different disease stages would strengthen the generalizability of our conclusions. Second, we focused exclusively on three major glomerular cell types&#x2014;podocytes, mesangial cells, and endothelial cells&#x2014;and did not explore other relevant populations such as immune cells, which are known to interact closely with glomerular cells. Third, our study lacks experimental functional validation of the key candidate genes identified. Direct evidence from gain- or loss-of-function experiments is needed to confirm their causal roles in disease pathogenesis, which remains an important objective for future research. Finally, the inclusion of a larger number of patient-derived samples will be essential to more comprehensively evaluate the consistency and translational relevance between mouse models and human disease. In summary, our study has generated a comprehensive and standardized scRNA-seq atlas of the murine glomerulus. We have demonstrated the key role of changes in cell composition in driving extensive expression differences, observed changes in cell type-specific gene expression, and identified patterns of injury under disease conditions. These findings provide important insights into kidney diseases and lay the foundation for future research aimed at understanding and treating kidney diseases.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>The pathogenic mechanisms of glomerular diseases&#x2014;both shared and unique across different types of glomerular diseases&#x2014;remain inadequately understood. By systematically comparing four distinct disease models and healthy controls, we uncovered two distinct response patterns and one common response across major cell types, and elucidates the pathogenic role of a novel disease-specific cell subpopulation in diabetic nephropathy.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Material</bold></xref>.</p></sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by The Ethics Committee of the Affiliated Hospital of Chengde Medical University. The study was conducted in accordance with the local legislation and institutional requirements.</p></sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>YH: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Conceptualization, Investigation. SL: Formal Analysis, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. SZL: Data curation, Writing &#x2013; review &amp; editing. SD: Visualization, Writing &#x2013; review &amp; editing. LH: Visualization, Writing &#x2013; review &amp; editing. JW: Writing &#x2013; review &amp; editing. LM: Writing &#x2013; review &amp; editing. CL: Writing &#x2013; review &amp; editing. QC: Conceptualization, Project administration, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>We thank all the participants of this study. We are grateful to the Gene Expression Omnibus (GEO) database, specifically dataset GSE146912, for supplying the data utilized in our research. We gratefully acknowledge the researchers who generated and shared these valuable public datasets, which made this integrative analysis possible.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2026.1763345/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2026.1763345/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table1.xlsx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"><label>Supplementary Table&#xa0;1</label>
<caption>
<p>Data information. Information for disease and control groups includes samples details.</p>
</caption></supplementary-material>
<supplementary-material xlink:href="Table2.xlsx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"><label>Supplementary Table&#xa0;2&#x2013;6</label>
<caption>
<p>Cluster information. The comprehensive details for each subset generated from every clustering step, including quality, annotations, marker genes, and their top 50 signature genes.</p>
</caption></supplementary-material>
<supplementary-material xlink:href="Table3.xlsx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table4.xlsx" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table5.xlsx" id="SM5" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Scott</surname> <given-names>RP</given-names></name>
<name><surname>Quaggin</surname> <given-names>SE</given-names></name>
</person-group>. 
<article-title>Review series: The cell biology of renal filtration</article-title>. <source>J Cell Biol</source>. (<year>2015</year>) <volume>209</volume>:<fpage>199</fpage>&#x2013;<lpage>210</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.201410017</pub-id>, PMID: <pub-id pub-id-type="pmid">25918223</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sethi</surname> <given-names>S</given-names></name>
<name><surname>De Vriese</surname> <given-names>AS</given-names></name>
<name><surname>Fervenza</surname> <given-names>FC</given-names></name>
</person-group>. 
<article-title>Acute glomerulonephritis</article-title>. <source>Lancet Lond Engl</source>. (<year>2022</year>) <volume>399</volume>:<page-range>1646&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(22)00461-5</pub-id>, PMID: <pub-id pub-id-type="pmid">35461559</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Anders</surname> <given-names>H-J</given-names></name>
<name><surname>Kitching</surname> <given-names>AR</given-names></name>
<name><surname>Leung</surname> <given-names>N</given-names></name>
<name><surname>Romagnani</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>Glomerulonephritis: immunopathogenesis and immunotherapy</article-title>. <source>Nat Rev Immunol</source>. (<year>2023</year>) <volume>23</volume>:<page-range>453&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-022-00816-y</pub-id>, PMID: <pub-id pub-id-type="pmid">36635359</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kopp</surname> <given-names>JB</given-names></name>
<name><surname>Anders</surname> <given-names>H-J</given-names></name>
<name><surname>Susztak</surname> <given-names>K</given-names></name>
<name><surname>Podest&#xe0;</surname> <given-names>MA</given-names></name>
<name><surname>Remuzzi</surname> <given-names>G</given-names></name>
<name><surname>Hildebrandt</surname> <given-names>F</given-names></name>
<etal/>
</person-group>. 
<article-title>Podocytopathies</article-title>. <source>Nat Rev Dis Primer</source>. (<year>2020</year>) <volume>6</volume>:<fpage>68</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41572-020-0196-7</pub-id>, PMID: <pub-id pub-id-type="pmid">32792490</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Haydak</surname> <given-names>J</given-names></name>
<name><surname>Azeloglu</surname> <given-names>EU</given-names></name>
</person-group>. 
<article-title>Role of biophysics and mechanobiology in podocyte physiology</article-title>. <source>Nat Rev Nephrol</source>. (<year>2024</year>) <volume>20</volume>:<page-range>371&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41581-024-00815-3</pub-id>, PMID: <pub-id pub-id-type="pmid">38443711</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qi</surname> <given-names>W</given-names></name>
<name><surname>Keenan</surname> <given-names>HA</given-names></name>
<name><surname>Li</surname> <given-names>Q</given-names></name>
<name><surname>Ishikado</surname> <given-names>A</given-names></name>
<name><surname>Kannt</surname> <given-names>A</given-names></name>
<name><surname>Sadowski</surname> <given-names>T</given-names></name>
<etal/>
</person-group>. 
<article-title>Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction</article-title>. <source>Nat Med</source>. (<year>2017</year>) <volume>23</volume>:<page-range>753&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm.4328</pub-id>, PMID: <pub-id pub-id-type="pmid">28436957</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Diez-Sampedro</surname> <given-names>A</given-names></name>
<name><surname>Lenz</surname> <given-names>O</given-names></name>
<name><surname>Fornoni</surname> <given-names>A</given-names></name>
</person-group>. 
<article-title>Podocytopathy in diabetes: a metabolic and endocrine disorder</article-title>. <source>Am J Kidney Dis Off. J Natl Kidney Found</source>. (<year>2011</year>) <volume>58</volume>:<page-range>637&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.ajkd.2011.03.035</pub-id>, PMID: <pub-id pub-id-type="pmid">21719174</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qian</surname> <given-names>Y</given-names></name>
<name><surname>Feldman</surname> <given-names>E</given-names></name>
<name><surname>Pennathur</surname> <given-names>S</given-names></name>
<name><surname>Kretzler</surname> <given-names>M</given-names></name>
<name><surname>Brosius</surname> <given-names>FC</given-names></name>
</person-group>. 
<article-title>From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy</article-title>. <source>Diabetes</source>. (<year>2008</year>) <volume>57</volume>:<page-range>1439&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db08-0061</pub-id>, PMID: <pub-id pub-id-type="pmid">18511444</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jourde-Chiche</surname> <given-names>N</given-names></name>
<name><surname>Fakhouri</surname> <given-names>F</given-names></name>
<name><surname>Dou</surname> <given-names>L</given-names></name>
<name><surname>Bellien</surname> <given-names>J</given-names></name>
<name><surname>Burtey</surname> <given-names>S</given-names></name>
<name><surname>Frimat</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Endothelium structure and function in kidney health and disease</article-title>. <source>Nat Rev Nephrol</source>. (<year>2019</year>) <volume>15</volume>:<fpage>87</fpage>&#x2013;<lpage>108</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41581-018-0098-z</pub-id>, PMID: <pub-id pub-id-type="pmid">30607032</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dejana</surname> <given-names>E</given-names></name>
<name><surname>Hirschi</surname> <given-names>KK</given-names></name>
<name><surname>Simons</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>The molecular basis of endothelial cell plasticity</article-title>. <source>Nat Commun</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>14361</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms14361</pub-id>, PMID: <pub-id pub-id-type="pmid">28181491</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>S</given-names></name>
<name><surname>Zhao</surname> <given-names>Y</given-names></name>
<name><surname>Lu</surname> <given-names>S</given-names></name>
<name><surname>Zhang</surname> <given-names>T</given-names></name>
<name><surname>Lindenmeyer</surname> <given-names>MT</given-names></name>
<name><surname>Nair</surname> <given-names>V</given-names></name>
<etal/>
</person-group>. 
<article-title>Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy</article-title>. <source>Genome Med</source>. (<year>2023</year>) <volume>15</volume>:<elocation-id>2</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13073-022-01145-4</pub-id>, PMID: <pub-id pub-id-type="pmid">36627643</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Deleersnijder</surname> <given-names>D</given-names></name>
<name><surname>Callemeyn</surname> <given-names>J</given-names></name>
<name><surname>Arijs</surname> <given-names>I</given-names></name>
<name><surname>Naesens</surname> <given-names>M</given-names></name>
<name><surname>Van Craenenbroeck</surname> <given-names>AH</given-names></name>
<name><surname>Lambrechts</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>Current methodological challenges of single-cell and single-nucleus RNA-sequencing in glomerular diseases</article-title>. <source>J Am Soc Nephrol JASN</source>. (<year>2021</year>) <volume>32</volume>:<page-range>1838&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.2021020157</pub-id>, PMID: <pub-id pub-id-type="pmid">34140401</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zambrano</surname> <given-names>S</given-names></name>
<name><surname>He</surname> <given-names>L</given-names></name>
<name><surname>Kano</surname> <given-names>T</given-names></name>
<name><surname>Sun</surname> <given-names>Y</given-names></name>
<name><surname>Charrin</surname> <given-names>E</given-names></name>
<name><surname>Lal</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Molecular insights into the early stage of glomerular injury in IgA nephropathy using single-cell RNA sequencing</article-title>. <source>Kidney Int</source>. (<year>2022</year>) <volume>101</volume>:<page-range>752&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.kint.2021.12.011</pub-id>, PMID: <pub-id pub-id-type="pmid">34968552</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Karaiskos</surname> <given-names>N</given-names></name>
<name><surname>Rahmatollahi</surname> <given-names>M</given-names></name>
<name><surname>Boltengagen</surname> <given-names>A</given-names></name>
<name><surname>Liu</surname> <given-names>H</given-names></name>
<name><surname>Hoehne</surname> <given-names>M</given-names></name>
<name><surname>Rinschen</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>A single-cell transcriptome atlas of the mouse glomerulus</article-title>. <source>J Am Soc Nephrol JASN</source>. (<year>2018</year>) <volume>29</volume>:<page-range>2060&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.2018030238</pub-id>, PMID: <pub-id pub-id-type="pmid">29794128</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>W-B</given-names></name>
<name><surname>Huang</surname> <given-names>G-R</given-names></name>
<name><surname>Liu</surname> <given-names>B-L</given-names></name>
<name><surname>Hu</surname> <given-names>H-K</given-names></name>
<name><surname>Geng</surname> <given-names>J</given-names></name>
<name><surname>Rui</surname> <given-names>H-L</given-names></name>
<etal/>
</person-group>. 
<article-title>Single cell landscape of parietal epithelial cells in healthy and diseased states</article-title>. <source>Kidney Int</source>. (<year>2023</year>) <volume>104</volume>:<page-range>108&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.kint.2023.03.036</pub-id>, PMID: <pub-id pub-id-type="pmid">37100348</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chung</surname> <given-names>J-J</given-names></name>
<name><surname>Goldstein</surname> <given-names>L</given-names></name>
<name><surname>Chen</surname> <given-names>Y-JJ</given-names></name>
<name><surname>Lee</surname> <given-names>J</given-names></name>
<name><surname>Webster</surname> <given-names>JD</given-names></name>
<name><surname>Roose-Girma</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Single-cell transcriptome profiling of the kidney glomerulus identifies key cell types and reactions to injury</article-title>. <source>J Am Soc Nephrol JASN</source>. (<year>2020</year>) <volume>31</volume>:<page-range>2341&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.2020020220</pub-id>, PMID: <pub-id pub-id-type="pmid">32651223</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bronstein</surname> <given-names>R</given-names></name>
<name><surname>Pace</surname> <given-names>J</given-names></name>
<name><surname>Gowthaman</surname> <given-names>Y</given-names></name>
<name><surname>Salant</surname> <given-names>DJ</given-names></name>
<name><surname>Mallipattu</surname> <given-names>SK</given-names></name>
</person-group>. 
<article-title>Podocyte-parietal epithelial cell interdependence in glomerular development and disease</article-title>. <source>J Am Soc Nephrol JASN</source>. (<year>2023</year>) <volume>34</volume>:<page-range>737&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.0000000000000104</pub-id>, PMID: <pub-id pub-id-type="pmid">36800545</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Benzing</surname> <given-names>T</given-names></name>
<name><surname>Salant</surname> <given-names>D</given-names></name>
</person-group>. 
<article-title>Insights into glomerular filtration and albuminuria</article-title>. <source>N Engl J Med</source>. (<year>2021</year>) <volume>384</volume>:<page-range>1437&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMra1808786</pub-id>, PMID: <pub-id pub-id-type="pmid">33852781</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Avraham</surname> <given-names>S</given-names></name>
<name><surname>Korin</surname> <given-names>B</given-names></name>
<name><surname>Chung</surname> <given-names>J-J</given-names></name>
<name><surname>Oxburgh</surname> <given-names>L</given-names></name>
<name><surname>Shaw</surname> <given-names>AS</given-names></name>
</person-group>. 
<article-title>The Mesangial cell - the glomerular stromal cell</article-title>. <source>Nat Rev Nephrol</source>. (<year>2021</year>) <volume>17</volume>:<page-range>855&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41581-021-00474-8</pub-id>, PMID: <pub-id pub-id-type="pmid">34508249</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bai</surname> <given-names>W-W</given-names></name>
<name><surname>Tang</surname> <given-names>Z-Y</given-names></name>
<name><surname>Shan</surname> <given-names>T-C</given-names></name>
<name><surname>Jing</surname> <given-names>X-J</given-names></name>
<name><surname>Li</surname> <given-names>P</given-names></name>
<name><surname>Qin</surname> <given-names>W-D</given-names></name>
<etal/>
</person-group>. 
<article-title>Up-regulation of paired-related homeobox 2 promotes cardiac fibrosis in mice following myocardial infarction by targeting of Wnt5a</article-title>. <source>J Cell Mol Med</source>. (<year>2020</year>) <volume>24</volume>:<page-range>2319&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcmm.14914</pub-id>, PMID: <pub-id pub-id-type="pmid">31880857</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>M</given-names></name>
<name><surname>Cai</surname> <given-names>Y</given-names></name>
<name><surname>Han</surname> <given-names>F</given-names></name>
<name><surname>Li</surname> <given-names>B</given-names></name>
<name><surname>Xu</surname> <given-names>Z</given-names></name>
<name><surname>Cui</surname> <given-names>K</given-names></name>
<etal/>
</person-group>. 
<article-title>Single-cell and bulk RNA-sequencing reveal PRRX2-driven cancer-associated fibroblast-mediated perineural invasion for predicting the immunotherapy outcome in colorectal cancer</article-title>. <source>Front Cell Dev Biol</source>. (<year>2025</year>) <volume>13</volume>:<elocation-id>1620388</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2025.1620388</pub-id>, PMID: <pub-id pub-id-type="pmid">41089673</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Prange</surname> <given-names>KHM</given-names></name>
<name><surname>Singh</surname> <given-names>AA</given-names></name>
<name><surname>Martens</surname> <given-names>JHA</given-names></name>
</person-group>. 
<article-title>The genome-wide molecular signature of transcription factors in leukemia</article-title>. <source>Exp Hematol</source>. (<year>2014</year>) <volume>42</volume>:<page-range>637&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exphem.2014.04.012</pub-id>, PMID: <pub-id pub-id-type="pmid">24814246</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ziliotto</surname> <given-names>R</given-names></name>
<name><surname>Gruca</surname> <given-names>MR</given-names></name>
<name><surname>Podder</surname> <given-names>S</given-names></name>
<name><surname>Noel</surname> <given-names>G</given-names></name>
<name><surname>Ogle</surname> <given-names>CK</given-names></name>
<name><surname>Hess</surname> <given-names>DA</given-names></name>
<etal/>
</person-group>. 
<article-title>PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1</article-title>. <source>Exp Hematol</source>. (<year>2014</year>) <volume>42</volume>:<fpage>204</fpage>&#x2013;<lpage>217.e1</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exphem.2013.11.011</pub-id>, PMID: <pub-id pub-id-type="pmid">24316397</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>J</given-names></name>
<name><surname>Miao</surname> <given-names>J</given-names></name>
<name><surname>Zhou</surname> <given-names>D</given-names></name>
<name><surname>Liao</surname> <given-names>J</given-names></name>
<name><surname>Wang</surname> <given-names>Z</given-names></name>
<name><surname>Lin</surname> <given-names>Z</given-names></name>
<etal/>
</person-group>. 
<article-title>Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension</article-title>. <source>Thromb Res</source>. (<year>2022</year>) <volume>218</volume>:<fpage>52</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.thromres.2022.08.006</pub-id>, PMID: <pub-id pub-id-type="pmid">35988445</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fan</surname> <given-names>M</given-names></name>
<name><surname>Yang</surname> <given-names>K</given-names></name>
<name><surname>Wang</surname> <given-names>X</given-names></name>
<name><surname>Wang</surname> <given-names>Y</given-names></name>
<name><surname>Tu</surname> <given-names>F</given-names></name>
<name><surname>Ha</surname> <given-names>T</given-names></name>
<etal/>
</person-group>. 
<article-title>Endothelial cell HSPA12B and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction</article-title>. <source>JCI Insight</source>. (<year>2020</year>) <volume>5</volume>:<fpage>e139640</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/jci.insight.139640</pub-id>, PMID: <pub-id pub-id-type="pmid">32790647</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ryseck</surname> <given-names>RP</given-names></name>
<name><surname>Bull</surname> <given-names>P</given-names></name>
<name><surname>Takamiya</surname> <given-names>M</given-names></name>
<name><surname>Bours</surname> <given-names>V</given-names></name>
<name><surname>Siebenlist</surname> <given-names>U</given-names></name>
<name><surname>Dobrzanski</surname> <given-names>P</given-names></name>
<etal/>
</person-group>. 
<article-title>RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B</article-title>. <source>Mol Cell Biol</source>. (<year>1992</year>) <volume>12</volume>:<page-range>674&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mcb.12.2.674-684.1992</pub-id>, PMID: <pub-id pub-id-type="pmid">1732739</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Engin</surname> <given-names>A</given-names></name>
</person-group>. 
<article-title>Reappraisal of adipose tissue inflammation in obesity</article-title>. <source>Adv Exp Med Biol</source>. (<year>2024</year>) <volume>1460</volume>:<fpage>297</fpage>&#x2013;<lpage>327</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-031-63657-8_10</pub-id>, PMID: <pub-id pub-id-type="pmid">39287856</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>Z</given-names></name>
<name><surname>Wei</surname> <given-names>M</given-names></name>
<name><surname>Wang</surname> <given-names>M</given-names></name>
<name><surname>Chen</surname> <given-names>L</given-names></name>
<name><surname>Liu</surname> <given-names>H</given-names></name>
<name><surname>Ren</surname> <given-names>Y</given-names></name>
<etal/>
</person-group>. 
<article-title>Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice</article-title>. <source>Inflammation</source>. (<year>2014</year>) <volume>37</volume>:<page-range>2020&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-014-9934-x</pub-id>, PMID: <pub-id pub-id-type="pmid">24958012</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ito</surname> <given-names>N</given-names></name>
<name><surname>Sakamoto</surname> <given-names>K</given-names></name>
<name><surname>Hikichi</surname> <given-names>C</given-names></name>
<name><surname>Matsusaka</surname> <given-names>T</given-names></name>
<name><surname>Nagata</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis</article-title>. <source>Am J Physiol Renal Physiol</source>. (<year>2020</year>) <volume>318</volume>:<page-range>F741&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajprenal.00414.2019</pub-id>, PMID: <pub-id pub-id-type="pmid">32068458</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>H</given-names></name>
<name><surname>Artomov</surname> <given-names>M</given-names></name>
<name><surname>Br&#xe4;hler</surname> <given-names>S</given-names></name>
<name><surname>Stander</surname> <given-names>MC</given-names></name>
<name><surname>Shamsan</surname> <given-names>G</given-names></name>
<name><surname>Sampson</surname> <given-names>MG</given-names></name>
<etal/>
</person-group>. 
<article-title>A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis</article-title>. <source>J Clin Invest</source>. (<year>2016</year>) <volume>126</volume>:<page-range>1067&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI82592</pub-id>, PMID: <pub-id pub-id-type="pmid">26901816</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>M</given-names></name>
<name><surname>Wang</surname> <given-names>L</given-names></name>
<name><surname>Shi</surname> <given-names>D-C</given-names></name>
<name><surname>Foo</surname> <given-names>J-N</given-names></name>
<name><surname>Zhong</surname> <given-names>Z</given-names></name>
<name><surname>Khor</surname> <given-names>C-C</given-names></name>
<etal/>
</person-group>. 
<article-title>Genome-wide meta-analysis identifies three novel susceptibility loci and reveals ethnic heterogeneity of genetic susceptibility for igA nephropathy</article-title>. <source>J Am Soc Nephrol JASN</source>. (<year>2020</year>) <volume>31</volume>:<page-range>2949&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.2019080799</pub-id>, PMID: <pub-id pub-id-type="pmid">32912934</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jiang</surname> <given-names>S</given-names></name>
<name><surname>Jia</surname> <given-names>H</given-names></name>
<name><surname>Hou</surname> <given-names>Q</given-names></name>
<name><surname>Jin</surname> <given-names>L</given-names></name>
<name><surname>Ahsan</surname> <given-names>MA</given-names></name>
<name><surname>Li</surname> <given-names>G</given-names></name>
<etal/>
</person-group>. 
<article-title>Multimodal analysis stratifies genetic susceptibility and reveals the pathogenic mechanism of kidney injury in diabetic nephropathy</article-title>. <source>Cell Rep Med</source>. (<year>2025</year>) <volume>6</volume>:<elocation-id>102249</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.xcrm.2025.102249</pub-id>, PMID: <pub-id pub-id-type="pmid">40712574</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zeng</surname> <given-names>C</given-names></name>
<name><surname>Zhang</surname> <given-names>H</given-names></name>
</person-group>. 
<article-title>Mechanisms of transgelin-2 in tumorigenesis</article-title>. <source>Discov Med</source>. (<year>2021</year>) <volume>32</volume>:<page-range>23&#x2013;8</page-range>., PMID: <pub-id pub-id-type="pmid">35219353</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qiu</surname> <given-names>Y</given-names></name>
<name><surname>Lei</surname> <given-names>C</given-names></name>
<name><surname>Zeng</surname> <given-names>J</given-names></name>
<name><surname>Xie</surname> <given-names>Y</given-names></name>
<name><surname>Cao</surname> <given-names>Y</given-names></name>
<name><surname>Yuan</surname> <given-names>Q</given-names></name>
<etal/>
</person-group>. 
<article-title>Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin</article-title>. <source>Mol Ther J Am Soc Gene Ther</source>. (<year>2023</year>) <volume>31</volume>:<page-range>3337&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ymthe.2023.09.003</pub-id>, PMID: <pub-id pub-id-type="pmid">37689970</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>X</given-names></name>
<name><surname>Ding</surname> <given-names>F</given-names></name>
<name><surname>Zhang</surname> <given-names>X</given-names></name>
<name><surname>Li</surname> <given-names>X</given-names></name>
<name><surname>Ding</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Cyclosporine A protects podocytes by regulating transgelin in adriamycin-induced podocyte injury</article-title>. <source>Kidney Blood Press Res</source>. (<year>2024</year>) <volume>49</volume>:<page-range>605&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000539700</pub-id>, PMID: <pub-id pub-id-type="pmid">38952124</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jiang</surname> <given-names>L</given-names></name>
<name><surname>Cui</surname> <given-names>H</given-names></name>
<name><surname>Ding</surname> <given-names>J</given-names></name>
<name><surname>Yang</surname> <given-names>A</given-names></name>
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
</person-group>. 
<article-title>Puromycin aminonucleoside-induced podocyte injury is ameliorated by the Smad3 inhibitor SIS3</article-title>. <source>FEBS Open Bio</source>. (<year>2020</year>) <volume>10</volume>:<page-range>1601&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/2211-5463.12916</pub-id>, PMID: <pub-id pub-id-type="pmid">32583562</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Banas</surname> <given-names>MC</given-names></name>
<name><surname>Banas</surname> <given-names>B</given-names></name>
<name><surname>Hudkins</surname> <given-names>KL</given-names></name>
<name><surname>Wietecha</surname> <given-names>TA</given-names></name>
<name><surname>Iyoda</surname> <given-names>M</given-names></name>
<name><surname>Bock</surname> <given-names>E</given-names></name>
<etal/>
</person-group>. 
<article-title>TLR4 links podocytes with the innate immune system to mediate glomerular injury</article-title>. <source>J Am Soc Nephrol JASN</source>. (<year>2008</year>) <volume>19</volume>:<page-range>704&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.2007040395</pub-id>, PMID: <pub-id pub-id-type="pmid">18256364</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Grgic</surname> <given-names>I</given-names></name>
<name><surname>Hofmeister</surname> <given-names>AF</given-names></name>
<name><surname>Genovese</surname> <given-names>G</given-names></name>
<name><surname>Bernhardy</surname> <given-names>AJ</given-names></name>
<name><surname>Sun</surname> <given-names>H</given-names></name>
<name><surname>Maarouf</surname> <given-names>OH</given-names></name>
<etal/>
</person-group>. 
<article-title>Discovery of new glomerular disease-relevant genes by translational profiling of podocytes <italic>in vivo</italic></article-title>. <source>Kidney Int</source>. (<year>2014</year>) <volume>86</volume>:<page-range>1116&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ki.2014.204</pub-id>, PMID: <pub-id pub-id-type="pmid">24940801</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>S</given-names></name>
<name><surname>Song</surname> <given-names>R</given-names></name>
<name><surname>Wang</surname> <given-names>Z</given-names></name>
<name><surname>Jing</surname> <given-names>Z</given-names></name>
<name><surname>Wang</surname> <given-names>S</given-names></name>
<name><surname>Ma</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>S100A8/A9 in inflammation</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>1298</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01298</pub-id>, PMID: <pub-id pub-id-type="pmid">29942307</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="web"><source>A human ALDH1A2 gene variant is associated with increased newborn kidney size and serum retinoic acid</source>. 
<publisher-name>PubMed</publisher-name>.
</mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rosselot</surname> <given-names>C</given-names></name>
<name><surname>Spraggon</surname> <given-names>L</given-names></name>
<name><surname>Chia</surname> <given-names>I</given-names></name>
<name><surname>Batourina</surname> <given-names>E</given-names></name>
<name><surname>Riccio</surname> <given-names>P</given-names></name>
<name><surname>Lu</surname> <given-names>B</given-names></name>
<etal/>
</person-group>. 
<article-title>Non-cell-autonomous retinoid signaling is crucial for renal development</article-title>. <source>Dev Camb Engl</source>. (<year>2010</year>) <volume>137</volume>:<page-range>283&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dev.040287</pub-id>, PMID: <pub-id pub-id-type="pmid">20040494</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Han</surname> <given-names>S-Y</given-names></name>
<name><surname>So</surname> <given-names>G-A</given-names></name>
<name><surname>Jee</surname> <given-names>Y-H</given-names></name>
<name><surname>Han</surname> <given-names>K-H</given-names></name>
<name><surname>Kang</surname> <given-names>Y-S</given-names></name>
<name><surname>Kim</surname> <given-names>H-K</given-names></name>
<etal/>
</person-group>. 
<article-title>Effect of retinoic acid in experimental diabetic nephropathy</article-title>. <source>Immunol Cell Biol</source>. (<year>2004</year>) <volume>82</volume>:<page-range>568&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1440-1711.2004.01287.x</pub-id>, PMID: <pub-id pub-id-type="pmid">15550114</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>W-B</given-names></name>
<name><surname>Fermin</surname> <given-names>D</given-names></name>
<name><surname>Xu</surname> <given-names>A-L</given-names></name>
<name><surname>Kopp</surname> <given-names>JB</given-names></name>
<name><surname>Xu</surname> <given-names>Q</given-names></name>
</person-group>. 
<article-title>Single-cell RNA sequencing data locate ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells</article-title>. <source>Exp Biol Med Maywood NJ</source>. (<year>2024</year>) <volume>249</volume>:<elocation-id>10167</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/ebm.2024.10167</pub-id>, PMID: <pub-id pub-id-type="pmid">39360029</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hamamura</surname> <given-names>K</given-names></name>
<name><surname>Matsunaga</surname> <given-names>N</given-names></name>
<name><surname>Ikeda</surname> <given-names>E</given-names></name>
<name><surname>Kondo</surname> <given-names>H</given-names></name>
<name><surname>Ikeyama</surname> <given-names>H</given-names></name>
<name><surname>Tokushige</surname> <given-names>K</given-names></name>
<etal/>
</person-group>. 
<article-title>Alterations of hepatic metabolism in chronic kidney disease via D-box-binding protein aggravate the renal dysfunction</article-title>. <source>J Biol Chem</source>. (<year>2016</year>) <volume>291</volume>:<page-range>4913&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M115.696930</pub-id>, PMID: <pub-id pub-id-type="pmid">26728457</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Resovi</surname> <given-names>A</given-names></name>
<name><surname>Pinessi</surname> <given-names>D</given-names></name>
<name><surname>Chiorino</surname> <given-names>G</given-names></name>
<name><surname>Taraboletti</surname> <given-names>G</given-names></name>
</person-group>. 
<article-title>Current understanding of the thrombospondin-1 interactome</article-title>. <source>Matrix Biol J Int Soc Matrix Biol</source>. (<year>2014</year>) <volume>37</volume>:<fpage>83</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.matbio.2014.01.012</pub-id>, PMID: <pub-id pub-id-type="pmid">24476925</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zheng</surname> <given-names>T</given-names></name>
<name><surname>Yang</surname> <given-names>R</given-names></name>
<name><surname>Li</surname> <given-names>X</given-names></name>
<name><surname>Dai</surname> <given-names>Z</given-names></name>
<name><surname>Xiang</surname> <given-names>H</given-names></name>
</person-group>. 
<article-title>Integrative transcriptome analysis reveals Serpine2 promotes glomerular mesangial cell proliferation and extracellular matrix accumulation via activating ERK1/2 signalling pathway in diabetic nephropathy</article-title>. <source>Diabetes Obes Metab</source>. (<year>2025</year>) <volume>27</volume>:<page-range>750&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/dom.16069</pub-id>, PMID: <pub-id pub-id-type="pmid">39557806</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Papke</surname> <given-names>CL</given-names></name>
<name><surname>Yanagisawa</surname> <given-names>H</given-names></name>
</person-group>. 
<article-title>Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies</article-title>. <source>Matrix Biol J Int Soc Matrix Biol</source>. (<year>2014</year>) <volume>37</volume>:<page-range>142&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.matbio.2014.02.004</pub-id>, PMID: <pub-id pub-id-type="pmid">24613575</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chavula</surname> <given-names>T</given-names></name>
<name><surname>To</surname> <given-names>S</given-names></name>
<name><surname>Agarwal</surname> <given-names>SK</given-names></name>
</person-group>. 
<article-title>Cadherin-11 and its role in tissue fibrosis</article-title>. <source>Cells Tissues Organs</source>. (<year>2023</year>) <volume>212</volume>:<fpage>293</fpage>&#x2013;<lpage>303</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000525359</pub-id>, PMID: <pub-id pub-id-type="pmid">35662129</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Poe</surname> <given-names>A</given-names></name>
<name><surname>Martinez Yus</surname> <given-names>M</given-names></name>
<name><surname>Wang</surname> <given-names>H</given-names></name>
<name><surname>Santhanam</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Lysyl oxidase like-2 in fibrosis and cardiovascular disease</article-title>. <source>Am J Physiol Cell Physiol</source>. (<year>2023</year>) <volume>325</volume>:<page-range>C694&#x2013;707</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.00176.2023</pub-id>, PMID: <pub-id pub-id-type="pmid">37458436</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>A&#xf1;azco</surname> <given-names>C</given-names></name>
<name><surname>Cerro</surname> <given-names>S</given-names></name>
<name><surname>Pereira</surname> <given-names>N</given-names></name>
<name><surname>Rojas</surname> <given-names>C</given-names></name>
<name><surname>Torres</surname> <given-names>&#xc1;</given-names></name>
<name><surname>Vidal-Beltr&#xe1;n</surname> <given-names>I</given-names></name>
</person-group>. 
<article-title>Dysregulation of lysyl oxidases expression in diabetic nephropathy and renal cell carcinoma</article-title>. <source>Curr Drug Targets</source>. (<year>2021</year>) <volume>22</volume>:<page-range>1916&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1389450122666210712163702</pub-id>, PMID: <pub-id pub-id-type="pmid">34879794</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gao</surname> <given-names>S</given-names></name>
<name><surname>Chen</surname> <given-names>H</given-names></name>
</person-group>. 
<article-title>Therapeutic potential of apelin and Elabela in cardiovascular disease</article-title>. <source>BioMed Pharmacother Biomed. Pharmacother</source>. (<year>2023</year>) <volume>166</volume>:<elocation-id>115268</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2023.115268</pub-id>, PMID: <pub-id pub-id-type="pmid">37562237</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Piera-Velazquez</surname> <given-names>S</given-names></name>
<name><surname>Jimenez</surname> <given-names>SA</given-names></name>
</person-group>. 
<article-title>Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases</article-title>. <source>Physiol Rev</source>. (<year>2019</year>) <volume>99</volume>:<page-range>1281&#x2013;324</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physrev.00021.2018</pub-id>, PMID: <pub-id pub-id-type="pmid">30864875</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Huveneers</surname> <given-names>S</given-names></name>
<name><surname>Phng</surname> <given-names>L-K</given-names></name>
</person-group>. 
<article-title>Endothelial cell mechanics and dynamics in angiogenesis</article-title>. <source>Curr Opin Cell Biol</source>. (<year>2024</year>) <volume>91</volume>:<elocation-id>102441</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ceb.2024.102441</pub-id>, PMID: <pub-id pub-id-type="pmid">39342870</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Phng</surname> <given-names>L-K</given-names></name>
<name><surname>Belting</surname> <given-names>H-G</given-names></name>
</person-group>. 
<article-title>Endothelial cell mechanics and blood flow forces in vascular morphogenesis</article-title>. <source>Semin Cell Dev Biol</source>. (<year>2021</year>) <volume>120</volume>:<fpage>32</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.semcdb.2021.06.005</pub-id>, PMID: <pub-id pub-id-type="pmid">34154883</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schnittler</surname> <given-names>H</given-names></name>
<name><surname>Taha</surname> <given-names>M</given-names></name>
<name><surname>Schnittler</surname> <given-names>MO</given-names></name>
<name><surname>Taha</surname> <given-names>AA</given-names></name>
<name><surname>Lindemann</surname> <given-names>N</given-names></name>
<name><surname>Seebach</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Actin filament dynamics and endothelial cell junctions: the Ying and Yang between stabilization and motion</article-title>. <source>Cell Tissue Res</source>. (<year>2014</year>) <volume>355</volume>:<page-range>529&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00441-014-1856-2</pub-id>, PMID: <pub-id pub-id-type="pmid">24643678</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1619848">Wu Liu</ext-link>, Capital Medical University, China</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2122270">Ronglu Yang</ext-link>, Anhui Provincial Hospital, China</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3118463">Wadih Issa</ext-link>, University of Texas Southwestern Medical Center, United States</p></fn>
</fn-group>
</back>
</article>